The agreement in two numbers Publication : Vivani Medical, Inc., official press release in agreement with Novo Nordisk B/S, published on Globe Newswire (July 7, 2026)
To overcome this, different modifications on the peptide structure were introduced to increase the receptor specificity and its signaling efficacy on the one side, and to increase the resistance against enzymatic degradation on the other side
It may also affect blood sugar regulation
Tirzepatide (Mounjaro, Zepbound) and retatrutide (Retara) are dual and triple agonists, not pure GLP-1 agonists
If your nausea really doesn't improve, your provider might also recommend a different GLP-1 receptor agonist or weight loss medication like: Tirzepatide (Mounjaro and Zepbound) Topiramate (Topamax) (Learn more about Ozempic Alternatives for Weight Loss.) One more thing and we don't want to scare you here, but it's an important point about semaglutide and nausea